Drug Detail

Information about Pemazyre

Generic Name	Pemigatinib
IND	INCB054828
Brand Name (US)	Pemazyre
Manufacturer	Incyte
Drug Type	Tyrosine Kinase Inhibitor
Delivery	Oral
Approval Status	Approved for a non-GIST cancer
Indications	Advanced bile duct cancer
Overall Strategy	Pan-FGFR inhibitor
Strategy	Block FGFR Pathway
Drug Category	SDH-directed

Links
	Prescribing information

Trials of this drug
	PEMIGIST: Phase 2 Study of Pemigatinib (INCB054828) in the Treatment of Patients With Advanced SDH-deficient Gastrointestinal Stromal Tumor (GIST)

Trial results